See All Slides - tctmd.com

Slides

Presentation TCT 2013

Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 4-Year Results from the BioFreedom First-In-Man Trial

Presenter: 208788|Ricardo Costa

October 29, 2013

Presentation TCT 2013

How Do I Identify a Culprit Lesion?

Presenter: Takashi Kubo

October 29, 2013

Presentation TCT 2013

How and When Do I Assess a Jailed Side Branch After Provisional Stenting?

Presenter: Bon-Kwon Koo

October 29, 2013

Presentation TCT 2013

Case Presentation and Topic Review: Why Does This Patient Have Outflow Tract Obstruction?

Presenter: Mark Sherrid

October 29, 2013

Presentation TCT 2013

Position Statement: Given the Advances in Stent Technology, Pharmacology, Imaging and Technique, All the Prior PCI vs. CABG Trials Are Archaic and Obsolete!

Presenter: Dean Kereiakes

October 29, 2013

Presentation TCT 2013

The SYNTAX Score Predicts Acute Kidney Injury After PCI for NSTEACS: Analysis from the ACUITY Trial

Presenter: Mahesh V. Madhavan

October 29, 2013

Presentation

Key Drivers in the Elective PCI Market

Presenter: Sunil Rao

October 29, 2013

Presentation TCT 2013

Early Vascular Restoration following treatment of single de-novo coronary artery lesions with the DESolve Nx Novolimus Eluting Bioresorbable Coronary Scaffold System (NEBCSS) at 6 months: Insights...

Presenter: J. Ribamar Costa Jr.

October 29, 2013

Presentation TCT 2013

CoreValve US Pivotal Study Design and Extreme Risk Results

Presenter: Steven Yakubov

October 29, 2013

Presentation TCT 2013

Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke

Presenter: Vivek Reddy

October 29, 2013

Advertisement

Slides

Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 4-Year Results from the BioFreedom First-In-Man Trial

How Do I Identify a Culprit Lesion?

How and When Do I Assess a Jailed Side Branch After Provisional Stenting?

Case Presentation and Topic Review: Why Does This Patient Have Outflow Tract Obstruction?

Position Statement: Given the Advances in Stent Technology, Pharmacology, Imaging and Technique, All the Prior PCI vs. CABG Trials Are Archaic and Obsolete!

The SYNTAX Score Predicts Acute Kidney Injury After PCI for NSTEACS: Analysis from the ACUITY Trial

Key Drivers in the Elective PCI Market

Early Vascular Restoration following treatment of single de-novo coronary artery lesions with the DESolve Nx Novolimus Eluting Bioresorbable Coronary Scaffold System (NEBCSS) at 6 months: Insights...

CoreValve US Pivotal Study Design and Extreme Risk Results

Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content